Cargando…
Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up
Background: Lobectomy with preservation of the contralateral lobe has already become the most preferred surgical method for patients with low-risk thyroid cancer. The incidence of and risk factors for the development of hypothyroidism after lobectomy for thyroid cancer remains unclear. The previous...
Autores principales: | Kim, Soo Young, Kim, Hee Jun, Kim, Seok-Mo, Chang, Hojin, Lee, Yong Sang, Chang, Hang-Seok, Park, Cheong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412630/ https://www.ncbi.nlm.nih.gov/pubmed/32849303 http://dx.doi.org/10.3389/fendo.2020.00520 |
Ejemplares similares
-
Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
por: Kim, Soo Young, et al.
Publicado: (2019) -
Survival With Lenvatinib for the Treatment of Progressive Anaplastic Thyroid Cancer: A Single-Center, Retrospective Analysis
por: Kim, Soo Young, et al.
Publicado: (2020) -
Lateral neck dissection for the treatment of synchronous and metachronous lateral neck metastasis of N1b papillary thyroid cancer
por: Yun, Hyeok Jun, et al.
Publicado: (2023) -
Primary thyroid lymphoma: A single-center experience
por: Lee, Jin Seok, et al.
Publicado: (2023) -
Adequacy and Effectiveness of Watson For Oncology in the Treatment of Thyroid Carcinoma
por: Yun, Hyeok Jun, et al.
Publicado: (2021)